Recently, Dr. Eric Topol weighed in on the use of pharmacogenomics and the benefits it offers to the average consumer. He argues, “What is needed is more scientific research to study the comprehensive list of commonly prescribed drugs, and implementation of these advances into day-to-day medical practice.”

Dr. Eric Topol is the Director of the Scripps Translational Science Institute in La Jolla, California.

“Eric Topol, the cardiologist who helped establish the effectiveness of several important blood thinners and who raised early concerns about the risks of the arthritis drug Vioxx, has a wonderful piece in the current issue of Science Translational Medicine, a research journal, speculating about how new genetic technologies could enter the health care system.” Click here to read more…

“We are all biologically unique, even those of us who have an ‘identical’ twin. The way we respond to a medication varies considerably, from being unresponsive, hyper-responsive, or developing serious side effects.” Click here to read more…

Comments are closed.